Evidence map›Paper›PMID 32799417›Full record

ArticleAnnals of neurology2020

Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study.

Pietro Maggi, Pascal Sati, Govind Nair, Irene C M Cortese, Steven Jacobson, Bryan R Smith, Avindra Nath, Joan Ohayon, Vincent van Pesch, Gaetano Perrotta and 10 more

3 registry-linked trialsAbstract readMulticenter Study
In one paragraph

Article in Annals of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 100 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05783934 nacompletednot on this mapstarted 2021, after this paper: background citation

Evaluation of the Degree of Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Positron Emission Tomography With Amyloid Markers (PET-CT 18F-Florbetaben) and Comparison With MRI Findings

TypeinterventionalSponsorIstituti Clinici Scientifici Maugeri SpARan2021 to 2024Enrolled6ConditionsMultiple SclerosisArms18F-florbetaben PET/CT
NCT06591429 recruitingnot on this mapstarted 2024, after this paper: background citation

Investigation of Smoldering Inflammation in Multiple Sclerosis

TypeobservationalSponsorWashington University School of MedicineRan2024 to 2027Enrolled25ConditionsMultiple SclerosisArmsRadiotracer [11C]-CS1P1, Radiotracer [11C]-DPA-713, anti-CD20 MS treatment, Radiotracer [12F]-FDG
NCT07705581 active not recruitingnot on this map

Validation and Standardization of Paramagnetic Rim Lesion (PRL) Identification in Multiple Sclerosis Across MAGNIMS Centers - From Scientific Setting Towards Clinical Applicability

TypeobservationalSponsorIRCCS San RaffaeleRan2017 to 2028Enrolled1,402ConditionsMultiple Sclerosis
3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. TAnnals of clinical and translational neurology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Pietro MaggiDepartment of Neurology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.ORCID 0000-0003-1697-5585
Pascal SatiDivision of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.
Govind NairDivision of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.
Irene C M CorteseDivision of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.
Steven JacobsonDivision of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.ORCID 0000-0003-3127-1287
Bryan R SmithDivision of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.
Avindra NathDivision of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.ORCID 0000-0003-0927-5855
Joan OhayonDivision of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.
Vincent van PeschDepartment of Neurology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Gaetano PerrottaDepartment of Neurology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0002-9795-1018
Caroline PotService of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Marie ThéaudinService of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-3026-3595
Vittorio MartinelliDepartments of Neurology and Neurophysiology and Neuroimaging Research Unit, Ospedale San Raffaele and Università Vita e Salute, Milan, Italy.
Roberta ScottiDepartment of Neuroradiology, Ospedale San Raffaele and Università Vita e Salute, Milan, Italy.
Tianxia WuClinical Trials Unit, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.
Renaud Du PasquierService of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Peter A CalabresiDepartment of Neurology, Johns Hopkins University, Baltimore, MD.ORCID 0000-0002-7776-6472
Massimo FilippiDepartments of Neurology and Neurophysiology and Neuroimaging Research Unit, Ospedale San Raffaele and Università Vita e Salute, Milan, Italy.ORCID 0000-0002-5485-0479
Daniel S ReichDivision of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.ORCID 0000-0001-6313-9884
Martina AbsintaDepartment of Neurology, Johns Hopkins University, Baltimore, MD.ORCID 0000-0003-0276-383X

Funding

Multimodal MRI in Multiple SclerosisZIANS003119 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI REICH, DANIEL · 2010 to 2025
$53.4M
Imaging Neurodegeneration in Multiple SclerosisR01NS082347 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PETER A CALABRESI, Shiv Saidha · 2013 to 2026
$7.0M
Intramural NIH HHS ZIA NS003119NINDS NIH HHS R01 NS082347
6 · The paper itself

Abstract

In multiple sclerosis (MS), a subset of chronic active white matter lesions are identifiable on magnetic resonance imaging by their paramagnetic rims, and increasing evidence supports their association with severity of clinical disease. We studied their potential role in differential diagnosis, screening an international multicenter clinical research-based sample of 438 individuals affected by different neurological conditions (MS, other inflammatory, infectious, and non-inflammatory conditions). Paramagnetic rim lesions, rare in other neurological conditions (52% of MS vs 7% of non-MS cases), yielded high specificity (93%) in differentiating MS from non-MS. Future prospective multicenter studies should validate their role as a diagnostic biomarker. ANN NEUROL 2020;88:1034-1042.

Indexed as

AdultAgedDiagnosis, DifferentialFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMultiple SclerosisNervous System DiseasesNeuroimagingPrevalenceRetrospective StudiesSensitivity and SpecificityYoung Adult

Identifiers

PMID32799417
PMCPMC9943711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.